Excursions, Recalls and Product You Cannot Trust

Part of Principal Investigator (PI) Training: Investigational Product Decisions.

About 4 minutes. Free, in your language, no account needed.

Why this matters

At some point a fridge alarm will go off, or a shipment will arrive with a temperature logger reading outside range, or the sponsor will recall a batch you have already dispensed. These happen at well-run sites and they happen at night.

The decision in every case is the same one, and it is medical: may this product still be given to a person? That is not a pharmacy question and not a logistics question.

Storage, and what the guideline actually says

Sections 2.10.4 and 2.10.5 require the investigational product to be stored as specified — by the sponsor, and in accordance with applicable regulatory requirements. Section 2.10.9 requires management that safeguards product integrity, its use per the protocol, and participant safety.

Note what the guideline does not contain. The words import, export and cold chain appear nowhere in E6(R3). Those obligations are national and regional law, and they are real — they are simply not ICH requirements, and it is worth knowing which is which when someone tells you "GCP requires" a particular shipping practice.

The excursion rule: quarantine first

The single most useful habit your site can have is this one, and it should be written down before the first shipment arrives:

Product that has been outside its specified conditions is quarantined and is not dispensed until the sponsor confirms in writing that it remains usable.

Quarantine means physically separated and labeled, not "we made a note". The decision on usability belongs to the sponsor, because they hold the stability data; the decision to keep it away from participants in the meantime belongs to you.

When an excursion happens, five things, in order:

  1. Quarantine immediately. Before anything else, including before working out who to tell.
  2. Capture the data — the actual temperature record, the duration, the minimum and maximum, not "it was out for a while".
  3. Notify the sponsor promptly, with that data.
  4. Establish whether any affected product was already dispensed or administered. This is the question that converts a logistics incident into a participant-safety one.
  5. Document, and find the mechanism. A propped-open fridge door, an alarm nobody hears at weekends, a delivery left at a loading bay.

Point 4 is where physicians earn their place in the process. If affected product reached a participant, you assess them, you decide whether an adverse event occurred, and you decide what they are told.

Recalls

A sponsor recall of a batch you have dispensed is the harder version of the same problem, with an added communication duty.

Expiry and re-labeling

Investigational product is often re-labeled with an extended expiry as new stability data arrives. Two rules keep this safe: only the sponsor may extend an expiry, and re-labeling is done by whoever the sponsor authorizes, documented, and never by improvisation at the site. Product past its labeled expiry with no documented extension is not dispensable, however inconvenient that is on the day.

Key takeaways